46% of NET patients are
diagnosed at an advanced stage
How Can I Help?
Latest News
NeuroEndocrine Cancer Australia Celebrates Groundbreaking PBS Recommendation of Life-Changing Treatment for Von Hippel-Lindau (VHL) Patients
Von Hippel-Lindau (VHL) patients and NeuroEndocrine Cancer Australia (NECA) celebrated across Australia this month when the only known treatment for VHL was recommended for listing as part of Australia’s Pharmaceutical Benefits Scheme (PBS). Until now access to...
NET Clinical Trials Explained for NET Patients in Taiwan at a TNEPTCA Seminar
Taiwan Neuroendocrine Tumor Patient Care Association (TNEPTCA) hosted a seminar on August 3, 2024 in Taipei, focused on clinical trials related to neuroendocrine tumors (NETs). Dr. Nai-Jung Chiang from Taipei Veterans General Hospital provided a clear explanation of...
New Podcast from LACNETS on NEN Treatments and Focus on Immunotherapy
Listen to the latest LACNETS podcast on "NEN Treatments: Focus on Immunotherapy," featuring Dr. Jennifer Eads. Learn about immunotherapy and how effective it is for neuroendocrine neoplasms (NENs). Dr. Jennifer Eads of Penn Medicine answers common questions about...